Live Breaking News & Updates on Scott Foglietta

Stay updated with breaking news from Scott foglietta. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Shareholder Alert: Bernstein Litowitz Berger & Grossmann LLP Announces the Filing of a Securities Class Action Lawsuit Against Danimer Scientific, Inc.


Shareholder Alert: Bernstein Litowitz Berger & Grossmann LLP Announces the Filing of a Securities Class Action Lawsuit Against Danimer Scientific, Inc.
05/18/2021 | 05:23pm EDT
Send by mail :
Message :
Required fields
NEW YORK, May 18, 2021 /PRNewswire/  Today, prominent investor rights law firm Bernstein Litowitz Berger & Grossmann LLP ( BLB&G ) filed a class action lawsuit for violations of the federal securities laws in the U.S. District Court for the Middle District of Georgia against Danimer Scientific, Inc. ( Danimer or the Company ) and certain of its senior executives (collectively, Defendants ).  The complaint expands the class period that was asserted in the previously filed related securities class action pending against Danimer captioned ....

New York , United States , Carlos Caballero , Scott Foglietta , Stephene Croskrey , Live Oak Acquisition Corp , Bernstein Litowitz Berger Grossmann , York Stock Exchange On , Danimer Scientific Inc , Us District Court , Kentucky Department Of Environmental Protection , Bernstein Litowitz Berger , Middle District , Danimer Scientific , New York Stock Exchange , Class Period , Wall Street Journal , Chief Technology Officer , Phil Van Trump , Ivan Trump , Spruce Point Capital Management , April Report , Kentucky Facility , Spruce Point , Information Act , Kentucky Department ,

Shareholder Alert: Bernstein Litowitz Berger & Grossmann LLP Announces the Filing of a Securities Class Action Lawsuit Against FibroGen, Inc.


Share this article
Share this article
NEW YORK, May 6, 2021 /PRNewswire/ Today, prominent investor rights law firm Bernstein Litowitz Berger & Grossmann LLP ( BLB&G ) filed a class action lawsuit for violations of the federal securities laws in the U.S. District Court for the Northern District of California against FibroGen, Inc. ( FibroGen or the Company ) and certain of its current and former senior executives (collectively, Defendants ). The complaint expands the class period that was asserted in the previously filed related securities class action pending against FibroGen captioned
Xu v. FibroGen, Inc., No. 3:21-cv-2623 (N.D. Cal.), and is brought on behalf of investors in FibroGen common stock between December 20, 2018 and April 6, 2021, inclusive (the Class Period ). ....

New York , United States , San Francisco , Scott Foglietta , Fibrogen Inc , Bernstein Litowitz Berger Grossmann , Drug Administration , Us District Court , Bernstein Litowitz Berger , Northern District , Class Period , Major Adverse Cardiac Events , New Drug Application , Private Securities Litigation Reform Act , Lead Plaintiff , Litowitz Berger , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , சான் பிரான்சிஸ்கோ , எங்களுக்கு மாவட்டம் நீதிமன்றம் , வடக்கு மாவட்டம் , வர்க்கம் காலம் , புதியது மருந்து விண்ணப்பம் , ப்ரைவேட் பத்திரங்கள் வழக்கு சீர்திருத்தம் நாடகம் ,